The largest database of trusted experimental protocols

Cd164

Manufactured by BioLegend
Sourced in United States

CD164 is a cell surface glycoprotein that functions as a sialomucin. It is expressed on various cell types, including hematopoietic stem and progenitor cells, endothelial cells, and some epithelial cells. CD164 plays a role in cell-cell and cell-matrix interactions, but its precise biological functions are still under investigation.

Automatically generated - may contain errors

5 protocols using cd164

1

Isolation and Characterization of Skeletal Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Femoral heads were obtained from young males, elderly males, premenopausal and postmenopausal females undergoing total hip arthroplasty. The bone marrow of the femoral head was isolated and human skeletal cells were separated from RBCs and bone dust by density gradient separation using 1:1 Histopaque 1.119 g/mL. The buffy coat was collected, washed with staining media, and the resulting cell suspension was depleted of CD45 + cells by magnetic-activated cell sorting (MACS). Cells were blocked with mouse IgG and stained with fluorochrome-conjugated antibodies against CD45 (Biolegend), CD235 (Biolegend), CD31(Invitrogen), CD202b (Biolegend), CD146 (Biolegend), Podoplanin (Invitrogen), CD164 (Biolegend), CD73 (Biolegend) at a dilution of 1:100. Flow cytometry was performed on FACS Aria II in the shared FACS Facility in the Lorry I. Lokey Stem Cell Institute. Gating schemes were established with fluorescence-minus-one (FMO) controls and 4’,6-diamidino-2-phenylindole (DAPI) was used for viability staining.
+ Open protocol
+ Expand
2

Isolation and Phenotyping of Human Skeletal Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human skeletal cells were separated from red blood cells (RBCs) and bone dust by density gradient separation using 1:1 Histopaque of density 1.119 g/mL (Sigma-Aldrich, St Louis, MO, USA). The buffy coat was collected, washed with staining media, and the resulting cell suspension was depleted of CD45 + cells by magnetic-activated cell sorting (MACS) (Miltenyi, Cat#130–045-801). Cells were blocked with mouse IgG and stained with fluorochrome-conjugated antibodies against CD45 (BioLegend, Cat#304029-BL), CD235a (BioLegend, Cat#306612-BL), CD31 (Thermo Fisher Scientific™, Cat#13–0319-82), CD202b (Tie-2) (BioLegend, Cat#334204), CD146 (BioLegend, Cat#342010), PDPN (Thermo Fisher Scientific™, Cat#17–9381-42), CD90 (THY1; BioLegend, Cat#328110), CD164 (BioLegend, Cat#324808), and CD73 (BioLegend, Cat#344016). Flow cytometry was performed on FACS Aria II (BD Biosciences). Gating schemes were established with fluorescence-minus-one (FMO: staining with all fluorophores except one) controls and negative propidium iodide (PI) (Sigma-Aldrich, Cat#P4170) staining (1 μg/ml) was used as a measure for cell viability.
+ Open protocol
+ Expand
3

Chondrocyte Phenotypic Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
The chondrocytes were fixed using a fixation/permeabilization solution kit (cat. no. 554715; BD Biosciences) and stained with CD34 (cat. no. 343607; BioLegend, Inc.; 1:100), CD44 (cat. no. 338807; BioLegend, Inc.; 1:100), CD59 (cat. no. 304711; BioLegend, Inc.; 1:100), CD74 (cat. no. 326811; BioLegend, Inc.; 1:100), CD90 (cat. no. 328109; BioLegend, Inc.; 1:100), CD105 (cat. no. 323205; BioLegend, Inc.; 1:100), CD146 (cat. no. 361015; BioLegend, Inc.; 1:100), CD164 (cat. no. 324805; BioLegend, Inc.; 1:100), SOX9-Alexa-647 (cat. no. 565493; BD Pharmingen; BD Biosciences; 1:200), ACAN-PE (cat. no. sc-33695; Santa Cruz Biotechnology, Inc.; 1:100), IgG1-Alexa-647 (cat. no. 557732; BD Pharmingen; BD Biosciences; 1:100), IgG1-PE (cat. no. 400112; BioLegend, Inc.; 1:100), IgG1-APC (cat. no. 400122; BioLegend, Inc.; 1:100), IgG1-FITC (cat. no. 400109; BioLegend, Inc.; 1:100) or IgG2a-APC (cat. no. 400221; BioLegend, Inc.; 1:100) for 30 min at 4˚C. The dilution of the antibody for FACS was ranged from 1:100-1:200. After staining, cells were washed with Perm/Wash Buffer (cat. no. 554715; BD Biosciences) and analyzed by flow cytometry (FACS Canto II; BD Biosciences). Data were analyzed using FlowJo version 10.7 software (FlowJo LLC).
+ Open protocol
+ Expand
4

Isolation and Characterization of Human Skeletal Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human skeletal cells were separated from red blood cells (RBCs) and bone dust by density gradient separation using 1:1 Histopaque of density 1.119 g/mL (Sigma-Aldrich, Cat#11191). The buffy coat was collected, washed with staining media, and the resulting cell suspension was depleted of CD45+ cells by magnetic-activated cell sorting (MACS) (Miltenyi, Cat#130–045-801). Cells were blocked with mouse IgG and stained with fluorochrome-conjugated antibodies against CD45 (BioLegend, Cat#304029-BL), CD235a (BioLegend, Cat#306612-BL), CD31 (Thermo Fisher Scientific™, Cat#13–0319-82), CD202b (Tie-2) (BioLegend, Cat#334204), CD146 (BioLegend, Cat#342010), PDPN (Thermo Fisher Scientific™, Cat#17–9381-42), CD90 (THY1; BioLegend, Cat#328110), CD164 (BioLegend, Cat#324808), and CD73 (BioLegend, Cat#344016). Flow cytometry was performed on FACS Aria II (BD Biosciences). Gating schemes were established with fluorescence-minus-one (FMO: staining with all fluorophores except one) controls and negative propidium iodide (PI) (Sigma-Aldrich, Cat#P4170) staining (1 μg/ml) was used as a measure for cell viability.
+ Open protocol
+ Expand
5

Characterization of Tendon and Muscle Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The tendon and muscle cells were washed with Perm/Wash buffer (554715; BD Biosciences, San Jose, CA, USA) and stained with Alkaline phosphatase (ALP; 327308; BioLegend, San Diego, CA, USA), CD11b (550019; BD Pharmingen, San Diego, CA, USA), CD34 (343607; BioLegend), CD45 (368511; BioLegend), CD59 (3044711; BioLegend), CD74 (326811; BioLegend), CD90 (328109; BioLegend), CD150 (323205; BioLegend), CD146 (361015; BioLegend), or CD164 (324805; BioLegend) for 30 min at 4 °C. Following staining, the cells were fixed using a fixation/permeabilization solution kit (554715; BD Biosciences) and washed with Perm/Wash buffer (554715; BD Biosciences). Stained cells were analyzed by flow cytometry (FACS Canto II; BD Biosciences) and data images were managed with Flowjo software (BD Biosciences; San Jose, CA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!